Longterm Followup of Rituximab Therapy in Patients with Rheumatoid Arthritis: Results from the Belgian MabThera in Rheumatoid Arthritis Registry

Our study reports the results of the MIRA (MabThera In Rheumatoid Arthritis) registry, set up to collect data about clinical usage, patient profile, and retention of rituximab (RTX) treatment in daily clinical practice in Belgium.

Publication year:2014

BOF-keylabel:yes

IOF-keylabel:yes

BOF-publication weight:2

CSS-citation score:2

Authors from:Hospital, Higher Education